Skip to main content

The International Society for Mild Approaches in Assisted Reproduction (ISMAAR) Definitions for Mild Stimulation and Their Rationale for Assisted Reproductive Technologies

  • Chapter
  • First Online:
Diminished Ovarian Reserve and Assisted Reproductive Technologies
  • 586 Accesses

Abstract

In order to increase the oocyte yield from a single in vitro fertilization (IVF) cycle, controlled ovarian stimulation (COS) protocols were developed. Increased daily doses of follicle-stimulating hormone (FSH) products in conventional COS protocols brought concerns about their association with ovarian hyperstimulation syndrome, multiple pregnancies due to the transfer of increased number of embryos to achieve pregnancy, increased embryonic aneuploidy, and inferior IVF outcomes. This leads to revisiting milder stimulation protocols for IVF. The International Society for Mild Approaches in Assisted Reproduction (ISMAAR) brought the definition for mild stimulation. Gentle approaches to IVF including natural cycle and mild and minimal stimulation protocols found acceptance especially in women with expected poor ovarian response, mostly due to diminished ovarian reserve and advanced reproductive age.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Steptoe PC, Edwards RG. Birth after the reimplantation of a human embryo. Lancet. 1978;2(8085):366.

    Article  CAS  Google Scholar 

  2. Fowler RE, Edwards RG, Walters DE, Chan ST, Steptoe PC. Steroidogenesis in preovulatory follicles of patients given human menopausal and chorionic gonadotrophins as judged by the radioimmunoassay of steroids in follicular fluid. J Endocrinol. 1978;77(2):161–9.

    Article  CAS  Google Scholar 

  3. Fowler RE, Fox NL, Edwards RG, Walters DE, Steptoe PC. Steroidogenesis by cultured granulosa cells aspirated from human follicles using pregnenolone and androgens as precursors. J Endocrinol. 1978;77(2):171–83.

    Article  CAS  Google Scholar 

  4. Jones HW Jr. In vitro fertilization comes to America. Memoir of a medical breakthrough. Williamsburg: Jamestown Bookworks; 2014. p. 234.

    Google Scholar 

  5. Jones HW Jr, Jones GS, Andrews MC, Acosta A, Bundren C, Garcia J, et al. The program for in vitro fertilization at Norfolk. Fertil Steril. 1982;38(1):14–21.

    Article  Google Scholar 

  6. Baart EB, Martini E, Eijkemans MJ, Van Opstal D, Beckers NG, Verhoeff A, et al. Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial. Hum Reprod. 2007;22(4):980–8.

    Article  Google Scholar 

  7. Kovacs P, Sajgo A, Kaali SG, Pal L. Detrimental effects of high-dose gonadotropin on outcome of IVF: making a case for gentle ovarian stimulation strategies. Reprod Sci. 2012;19(7):718–24.

    Article  CAS  Google Scholar 

  8. Edwards RG. IVF, IVM, natural cycle IVF, minimal stimulation IVF – time for a rethink. Reprod Biomed Online. 2007;15(1):106–19.

    Article  CAS  Google Scholar 

  9. Xu YW, Peng YT, Wang B, Zeng YH, Zhuang GL, Zhou CQ. High follicle-stimulating hormone increases aneuploidy in human oocytes matured in vitro. Fertil Steril. 2011;95(1):99–104.

    Article  CAS  Google Scholar 

  10. Arce JC, Andersen AN, Fernandez-Sanchez M, Visnova H, Bosch E, Garcia-Velasco JA, et al. Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimullerian hormone-stratified, dose-response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection. Fertil Steril. 2014;102(6):1633–40 e5.

    Article  CAS  Google Scholar 

  11. von Wolff M, Kollmann Z, Fluck CE, Stute P, Marti U, Weiss B, et al. Gonadotrophin stimulation for in vitro fertilization significantly alters the hormone milieu in follicular fluid: a comparative study between natural cycle IVF and conventional IVF. Hum Reprod. 2014;29(5):1049–57.

    Article  Google Scholar 

  12. Kollmann Z, Schneider S, Fux M, Bersinger NA, von Wolff M. Gonadotrophin stimulation in IVF alters the immune cell profile in follicular fluid and the cytokine concentrations in follicular fluid and serum. Hum Reprod. 2017;32(4):820–31.

    Article  CAS  Google Scholar 

  13. Out HJ, Braat DD, Lintsen BM, Gurgan T, Bukulmez O, Gokmen O, et al. Increasing the daily dose of recombinant follicle stimulating hormone (Puregon) does not compensate for the age-related decline in retrievable oocytes after ovarian stimulation. Hum Reprod. 2000;15(1):29–35.

    Article  CAS  Google Scholar 

  14. Lensen SF, Wilkinson J, Leijdekkers JA, La Marca A, Mol BWJ, Marjoribanks J, et al. Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI). Cochrane Database Syst Rev. 2018;(2):CD012693.

    Google Scholar 

  15. van Tilborg TC, Oudshoorn SC, Eijkemans MJC, Mochtar MH, van Golde RJT, Hoek A, et al. Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis. Hum Reprod. 2017;32(12):2485–95.

    Article  Google Scholar 

  16. van Tilborg TC, Torrance HL, Oudshoorn SC, Eijkemans MJC, Koks CAM, Verhoeve HR, et al. Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 1: the predicted poor responder. Hum Reprod. 2017;32(12):2496–505.

    Article  Google Scholar 

  17. Oudshoorn SC, van Tilborg TC, Hamdine O, Torrance HL, Eijkemans MJC, Lentjes E, et al. Ovarian response to controlled ovarian hyperstimulation: what does serum FSH say? Hum Reprod. 2017;32(8):1701–9.

    Article  CAS  Google Scholar 

  18. Baker VL, Brown MB, Luke B, Smith GW, Ireland JJ. Gonadotropin dose is negatively correlated with live birth rate: analysis of more than 650,000 assisted reproductive technology cycles. Fertil Steril. 2015;104(5):1145–52 e1-5.

    Article  CAS  Google Scholar 

  19. Baker VL. Mild ovarian stimulation for in vitro fertilization: one perspective from the USA. J Assist Reprod Genet. 2013;30(2):197–202.

    Article  Google Scholar 

  20. Nargund G, Datta AK, Fauser B. Mild stimulation for in vitro fertilization. Fertil Steril. 2017;108(4):558–67.

    Article  Google Scholar 

  21. Nargund G, Fauser BC, Macklon NS, Ombelet W, Nygren K, Frydman R, et al. The ISMAAR proposal on terminology for ovarian stimulation for IVF. Hum Reprod. 2007;22(11):2801–4.

    Article  CAS  Google Scholar 

  22. Teramoto S, Kato O. Minimal ovarian stimulation with clomiphene citrate: a large-scale retrospective study. Reprod Biomed Online. 2007;15(2):134–48.

    Article  CAS  Google Scholar 

  23. Papaleo E, De Santis L, Fusi F, Doldi N, Brigante C, Marelli G, et al. Natural cycle as first approach in aged patients with elevated follicle-stimulating hormone undergoing intracytoplasmic sperm injection: a pilot study. Gynecol Endocrinol. 2006;22(7):351–4.

    Article  Google Scholar 

  24. Morgia F, Sbracia M, Schimberni M, Giallonardo A, Piscitelli C, Giannini P, et al. A controlled trial of natural cycle versus microdose gonadotropin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization. Fertil Steril. 2004;81(6):1542–7.

    Article  CAS  Google Scholar 

  25. Bassil S, Godin PA, Donnez J. Outcome of in-vitro fertilization through natural cycles in poor responders. Hum Reprod. 1999;14(5):1262–5.

    Article  CAS  Google Scholar 

  26. Hohmann FP, Macklon NS, Fauser BC. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol. J Clin Endocrinol Metab. 2003;88(1):166–73.

    Article  CAS  Google Scholar 

  27. Casano S, Guidetti D, Patriarca A, Pittatore G, Gennarelli G, Revelli A. MILD ovarian stimulation with GnRH-antagonist vs. long protocol with low dose FSH for non-PCO high responders undergoing IVF: a prospective, randomized study including thawing cycles. J Assist Reprod Genet. 2012;29(12):1343–51.

    Article  Google Scholar 

  28. Verberg MF, Eijkemans MJ, Macklon NS, Heijnen EM, Fauser BC, Broekmans FJ. Predictors of ongoing pregnancy after single-embryo transfer following mild ovarian stimulation for IVF. Fertil Steril. 2008;89(5):1159–65.

    Article  Google Scholar 

  29. Practice Committee of the American Society for Reproductive Medicine. Electronic address, ASRM@asrm.org. Comparison of pregnancy rates for poor responders using IVF with mild ovarian stimulation versus conventional IVF: a guideline. Fertil Steril. 2018;109(6):993–9.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Orhan Bukulmez .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Bukulmez, O. (2020). The International Society for Mild Approaches in Assisted Reproduction (ISMAAR) Definitions for Mild Stimulation and Their Rationale for Assisted Reproductive Technologies. In: Bukulmez, O. (eds) Diminished Ovarian Reserve and Assisted Reproductive Technologies. Springer, Cham. https://doi.org/10.1007/978-3-030-23235-1_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-23235-1_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-23234-4

  • Online ISBN: 978-3-030-23235-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics